H.C. Wainwright has initiated Adverum Biotechnologies (NASDAQ:ADVM) with a buy rating saying that its wet AMD gene therapy candidate, ixoberogene soroparvovec (lxo-vec), could become an alternative to...
Source LinkH.C. Wainwright has initiated Adverum Biotechnologies (NASDAQ:ADVM) with a buy rating saying that its wet AMD gene therapy candidate, ixoberogene soroparvovec (lxo-vec), could become an alternative to...
Source Link
Comments